Prokidney (PROK) Accounts Payables (2021 - 2026)
Prokidney (PROK) reported Accounts Payables of $2.6 million for Q1 2026, down 16.98% year-over-year from $3.1 million in Q1 2025, and up 175.74% quarter-over-quarter from $940000.0 in Q4 2025.
Prokidney (PROK) Accounts Payables (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Accounts Payables data on file, last reported at $2.6 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $2.6 million, down 16.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 16.98% YoY), and the FY2025 annual result was $940000.0, down 74.13% from the prior year.
- Accounts Payables climbed to $2.6 million in Q1 2026 per PROK's latest filing, from $940000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $5.1 million in Q4 2023 and troughed at $26735.0 in Q1 2022.
- A 5-year average of $2.9 million and a median of $3.0 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 20259.67% in 2022, then slumped 74.13% in 2025.
- A 5-year view of Accounts Payables shows it stood at $3.0 million in 2022, then surged by 67.48% to $5.1 million in 2023, then dropped by 28.74% to $3.6 million in 2024, then tumbled by 74.13% to $940000.0 in 2025, then soared by 175.74% to $2.6 million in 2026.
- Business Quant data shows PROK's Accounts Payables at $2.6 million in Q1 2026, $940000.0 in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 940,000.00 |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 4.48 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 3.45 Mn |
| Mar 31, 2022 | 26,735.00 |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 16,960.00 |